Building evidence and measuring clinical outcomes for genomic medicine
- PMID: 31395443
- PMCID: PMC6730663
- DOI: 10.1016/S0140-6736(19)31278-4
Building evidence and measuring clinical outcomes for genomic medicine
Abstract
Human genomic sequencing has potential diagnostic, prognostic, and therapeutic value across a wide breadth of clinical disciplines. One barrier to widespread adoption is the paucity of evidence for improved outcomes in patients who do not already have an indication for more focused testing. In this Series paper, we review clinical outcome studies in genomic medicine and discuss the important features and key challenges to building evidence for next generation sequencing in the context of routine patient care.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures
References
-
- Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 2011; 470: 204–13. - PubMed
-
- Wetterstrand K DNA Sequencing Costs: Data. National Human Genome Research Institute (NHGRI) https://www.genome.gov/27541954/dna-sequencing-costs-data/ (accessed Nov 15, 2018).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
